These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 19111794)

  • 1. SUO/SBUR 2007 annual meeting proceedings: overview.
    Evans CP
    Urol Oncol; 2009; 27(1):33. PubMed ID: 19111794
    [No Abstract]   [Full Text] [Related]  

  • 2. Highlights of the 2008 SUO/SBUR annual meeting: current controversies in urologic oncology.
    Kibel AS
    Urol Oncol; 2009; 27(3):293-4. PubMed ID: 19414114
    [No Abstract]   [Full Text] [Related]  

  • 3. 2007 Annual Meeting of the Society of Urologic Oncology and the Society of Basic Urologic Research: Introduction.
    Mohler JL
    Urol Oncol; 2009; 27(1):34-5. PubMed ID: 19111795
    [No Abstract]   [Full Text] [Related]  

  • 4. [Urology].
    Jichlinski P
    Rev Med Suisse; 2014 Jan; 10(412-413):127-9. PubMed ID: 24558917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Best approach for low-risk superficial bladder cancer.
    Solsona E
    ScientificWorldJournal; 2006 Oct; 6():2638-45. PubMed ID: 17619742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urological oncology in Europe. Research highlights from the XVIIth congress of the European Association of Urology, Birmingham, UK, February 23-26, 2002.
    Thompson E
    Drugs Today (Barc); 2002 Apr; 38(4):221-34. PubMed ID: 12532191
    [No Abstract]   [Full Text] [Related]  

  • 7. [Update urooncology: news with clinical relevance from major scientific meetings 2012].
    Hegele A; Skrobek L; Schrader AJ
    Aktuelle Urol; 2012 Dec; 43(6):376-87. PubMed ID: 23254351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Uro-oncological research from the laboratory and clinical practice].
    Engeler D; Ludewig B; Schmid HP
    Urologe A; 2008 Aug; 47(8):978-81. PubMed ID: 18521561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bladder cancer update: what was new at the 2010 annual congress of the German Association of Urology in Düsseldorf?].
    Nawroth R; Hartmann A; Olbert PJ; Merseburger AS; Stöhr R; Knüchel R; Retz M; Füssel S
    Urologe A; 2011 Feb; 50(2):221-6. PubMed ID: 21246347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New strategies in the treatment of Ta-T1 transitional cell carcinoma (TCC) of the bladder.
    Brausi MA
    ScientificWorldJournal; 2006 Oct; 6():2632-7. PubMed ID: 17619741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The history and future of the Urologic Oncology Study Group (UOSG) of the Japan Clinical Oncology Group (JCOG).
    Tobisu K
    Jpn J Clin Oncol; 2012 May; 42(5):363-7. PubMed ID: 22450928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Artificial Intelligence - Changing the Field of Prostate Cancer?
    Rohan P; O'Reilly MK; Nason GJ
    Ir Med J; 2020 Mar; 113(3):45. PubMed ID: 32815705
    [No Abstract]   [Full Text] [Related]  

  • 13. 6th Meeting of the European Society of Oncological Urology.
    Govorov A
    Expert Rev Anticancer Ther; 2009 Apr; 9(4):397-9. PubMed ID: 19374594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we underutilizing minimally invasive approaches for upper tract urothelial carcinoma?
    Wolf JS
    Urol Oncol; 2009; 27(1):75-80. PubMed ID: 19111803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of variant histology on the outcome of bladder cancer treated with curative intent.
    Black PC; Brown GA; Dinney CP
    Urol Oncol; 2009; 27(1):3-7. PubMed ID: 18367107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Aspects of bladder cancer].
    Jocham D; Stöckle M; Sommerauer M
    Urologe A; 2012 Jun; 51(6):783. PubMed ID: 22674507
    [No Abstract]   [Full Text] [Related]  

  • 17. What's new in urology.
    Williams RD
    J Am Coll Surg; 2002 Nov; 195(5):663-74. PubMed ID: 12437254
    [No Abstract]   [Full Text] [Related]  

  • 18. Food and Drug Administration process for development and approval of drugs and radiopharmaceuticals: treatments in urologic oncology.
    Ning YM; Maher VE
    Urol Oncol; 2015 Mar; 33(3):137-42. PubMed ID: 25613202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Artificial intelligences in urological practice: the key to success?
    Cai T; Conti G; Lorenzini M; Bartoletti R
    Ann Oncol; 2007 Mar; 18(3):604-5. PubMed ID: 17158777
    [No Abstract]   [Full Text] [Related]  

  • 20. In memoriam: a curious and careful gentleman--John P. Donohue, M.D.
    Koch M; Nichols C
    Urol Oncol; 2009; 27(1):1-2. PubMed ID: 19111793
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.